|
C6ORF106 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.414130E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.837800E-04 |
| Normal-vs-Stage2 |
4.391000E-01 |
| Normal-vs-Stage3 |
3.078700E-03 |
| Normal-vs-Stage4 |
2.399900E-02 |
| Stage1-vs-Stage2 |
1.761160E-01 |
| Stage1-vs-Stage3 |
7.688800E-01 |
| Stage1-vs-Stage4 |
8.832600E-01 |
| Stage2-vs-Stage3 |
2.019400E-01 |
| Stage2-vs-Stage4 |
2.961400E-01 |
| Stage3-vs-Stage4 |
9.412200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.3152999999998E-05 |
| Normal-vs-AfricanAmerican |
8.219600E-01 |
| Normal-vs-Asian |
9.148200E-01 |
| Caucasian-vs-AfricanAmerican |
1.442210E-03 |
| Caucasian-vs-Asian |
4.062000E-01 |
| AfricanAmerican-vs-Asian |
8.334400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.386100E-02 |
| Normal-vs-Female |
1.76250000039069E-07 |
| Male-vs-Female |
7.155000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.516000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.191140E-04 |
| Normal-vs-Age(61-80Yrs) |
1.101320E-03 |
| Normal-vs-Age(81-100Yrs) |
2.937800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.324380E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.324000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.732230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.964200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.143400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.919000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.490400E-02 |
| Normal-vs-Grade 2 |
8.817600E-04 |
| Normal-vs-Grade 3 |
8.636600E-04 |
| Normal-vs-Grade 4 |
8.970400E-02 |
| Grade 1-vs-Grade 2 |
1.515250E-01 |
| Grade 1-vs-Grade 3 |
2.621200E-01 |
| Grade 1-vs-Grade 4 |
2.096600E-01 |
| Grade 2-vs-Grade 3 |
7.228800E-01 |
| Grade 2-vs-Grade 4 |
7.510800E-01 |
| Grade 3-vs-Grade 4 |
5.847600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.44409997480255E-09 |
| Normal-vs-ccB subtype |
1.117210E-01 |
| ccA subtype-vs-ccB subtype |
3.621000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.55900000000143E-05 |
| Normal-vs-N1 |
1.605170E-01 |
| N0-vs-N1 |
6.156200E-01 |
|
|
